Global Health Policy Blog

CGD experts blog on global health issues such as health financing, drug resistance, clinical trials, vaccine development, HIV/AIDS, and health-related foreign assistance.

 

PEPFAR is Life for Millions—But without Better Prevention, the AIDS Burden Doubles Every 28 Years

Without PEPFAR, it’s safe to say that almost all of Africa would be stuck near zero HIV treatment coverage. Instead, 49 percent of HIV-infected people were receiving life-saving treatment in 2014, rising to 56 percent by 2015, and the top-performing countries are still gaining ground. This dramatic increase in treatment coverage is a prodigious achievement—and the United States deserves most of the credit. But despite these accomplishments, much more work is needed to reach the end of the epidemic.

GAO Report Misses the Point on USG Ebola Response

Having tried and mostly failed to track what was going on with US Government performance and spending on Ebola, I welcome the GAO’s overview of obligations and disbursements by appropriation account and strategy pillar. Now the scope of this report appears to be narrow, so let’s hope there’s more to come. A performance audit should go beyond the money to look at what actually happened; what organizations, activities and products were funded; what were the results on the outcomes that matter—Ebola transmission, rapid control of Ebola outbreaks; whether second-order economic impacts were mitigated; and how outbreak preparedness has evolved over time.

Dear Donors: Three Recommendations to Accelerate Progress Toward the Global Family Planning Goals

CGD’s new report on family planning, Aligning to 2020: How the FP2020 Core Partners Can Work Better, Together, offers three big recommendations for donors on the path to 2020. They are laid out in greater detail later in this blog, but in brief we urge donors to be more strategic and collaborative in how resources area allocated at the national level; we would like to see stronger incentives developed and rolled out for co-financing and performance; and we encourage greater accountability and learning across the results chain.

FP2020: Three Things to Ask About Next Week’s Progress Report

The Family Planning 2020 (FP2020) initiative hit its midpoint this year, about four years after its launch by global health leaders in 2012. Set up to “expand access to family planning information, services, and supplies to an additional 120 million women and girls in 69 of the world’s poorest countries by 2020,” the initiative has faced the usual cat herding challenges that go along with its expansive mandate to recruit new funding commitments, track actual spending, coordinate donors and country actions, report on trends in contraceptive prevalence and other FP2020 goals, serve as a clearinghouse for data and knowledge, work with countries to do better planning, and serve as a global voice and advocate.

Data Revolutionaries: Routine Administrative Data Can Be Sexy Too

Routine operational data on government programs lack sexiness, and are generally not trendy with Data Revolutionaries. But unlike censuses and household surveys, routine administrative data are readily available at low cost, cover key populations and service providers, and are generally at the right level of disaggregation for decision-making on payment and service delivery. Despite their potential utility, these data remain an under-appreciated asset for generating evidence and informing policy.

Getting Serious on Global Health Security

Zika’s rapid spread has focused media attention on how poorly prepared both rich and less rich countries are for infectious disease outbreaks. And while it seems that we are still flailing, in fact, the international community has been trying to do better for a while. Perhaps the most significant response came in 2014 when the G7 (including the US Government) endorsed the Global Health Security Agenda (GHSA), a partnership of governments and international organizations aiming to accelerate achievement of the core outbreak preparedness and response capacities required by the International Health Regulations.

Water Water Everywhere? A World Water Week Q&A with Louis Boorstin

In his previous role as head of water, sanitation, and hygiene (WASH) at the Bill & Melinda Gates Foundation, Louis Boorstin worked to co-invest with the World Bank in at-scale programs that would be rigorously evaluated. The unique result: lives saved in the real world, measured rigorously, with lessons about what did and didn’t work so well. As experts, practitioners, and advocates gather in Stockholm to celebrate World Water Week, here’s a Q&A with Louis—in his own words—on what he’s learned from his experience:

Pages

Global Health Policy Blog

Tags

Experts